# Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects

> **NCT01986608** · PHASE1 · COMPLETED · sponsor: **UCB Pharma SA** · enrollment: 26 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Lacosamide infusion
- **DRUG:** Lacosamide oral

## Key facts

- **NCT ID:** NCT01986608
- **Lead sponsor:** UCB Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986608, "Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01986608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
